Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for rare cardiopulmonary diseases in the United States. The company's lead product candidates include YUTREPIA, an inhaled dry po...
Leadership
Roger A. Jeffs Ph.D.
CEO & Director
Michael Kaseta
COO & CFO
Russell Schundler
General Counsel & Corporate Secretary
Scott Moomaw
Chief Commercial Officer
Rajeev Saggar M.D.
Chief Medical Officer
Dana Boyle
Chief Accounting Officer
Christian Perez Font
Senior VP, Chief Compliance Officer & Associate General Counsel
